Bahrain has granted emergency use authorization to the COVID-19 vaccine developed by France’s Valneva, the company said in a statement on Tuesday.
Valneva expects to deliver the first shipments of its VLA2001 vaccine to the kingdom at the end of March, after it signed an advance purchase deal for one million doses in December last year.
“As the only dual-adjuvanted, inactivated COVID-19 vaccine approved in Bahrain, VLA2001 will provide a differentiated vaccine option to the Bahraini population and medical community,” said CEO Thomas Lingelbach.
Late last month, the company had said it expected to start shipments of its vaccine in Europe soon after it is recommended for conditional approval at the end of March, as it received a list of questions in an initial regulatory assessment.
COVAX’s supply of COVID-19 vaccines outweighs demand for first timeThe global project to share COVID-19 vaccines is struggling to place more than 300 million doses in the latest sign the problem with vaccinating the ... Coronavirus
Immunity reaches peak in two weeks after third COVID-19 vaccine dose: Saudi officialImmunity against COVID- 19 starts days after taking the third dose and reaches its peak after two weeks, Saudi Arabia’s Assistant Minister of Health ... Coronavirus
Bahrain bans travelers from southern African states over COVID-19 concernsBahrain has banned entry to travelers from South Africa and five southern African nations due to concerns related to the spread of COVID-19, the state ... Coronavirus